PD-1 Antibody + XELOX in 1st Line Serum A-fetoprotein (AFP)-Elevated Gastric or Gastroesophageal Junction Adenocarcinoma

NCT04098796 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Gastric or Gastroesophageal Junction Adenocarcinoma
AFP

Interventions

DRUG: Anti-PD-1 antibody
DRUG: XELOX

Sponsor

China Medical University, China